That is a great question. It's a question that keeps me up at night as well. We've been on a declining basis. We are reaching a tipping point, I would say, in terms of our funding model. We've done a number of cost-cutting exercises over the last number of years. The objective of the CPMA is to run a zero balance, if you will, where expenses equal revenues each year. We've been fairly successful at doing that in the last number of years, but it's becoming increasingly difficult.
About 65% of the budget for the CPMA is to deliver the equine drug control program, the anti-doping program. Science is expensive. Testing is expensive. Keeping on top of the science is tough. We are in a situation where there's tremendous pressure, absolutely.